Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-11 20:24 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Connective Tissue Matrix Compared to Steroid Injections for Rotator Cuff Tendinopathy
NCT06712290 · Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) · NA · withdrawn · last registry update 2025-12-23 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “No participants met eligibility and the study was closed.” | – | Registry record, Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against CRBN within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2026-11-02Results posted on the registry: Joseph Tuscano, Clarithromycin + Dexamethasone (NCT02542657)
- 2026-11-02Phase 3 first posted: Keymed Biosciences Co.Ltd, CM336 + CM313 (NCT07910903)
- 2026-10-19Also stopped (suspended): National Cancer Institute (NCI), Iberdomide (NCT06179888)
- 2026-10-02Also stopped (suspended): Alliance for Clinical Trials in Oncology, Iberdomide + Belantamab Mafodotin (NCT06232044)
- 2026-09-28Also stopped (terminated): Mayo Clinic, Dexamethasone + Lenalidomide (NCT05288062)
- 2026-09-25Results posted on the registry: Memorial Sloan Kettering Cancer Center, Pomalidomide + Dexamethasone (NCT01745588)
- 2026-08-19Phase 3 first posted: CellCentric Ltd., InoPd + Investigator's choice of SAT (NCT07772024)
- 2026-08-03Phase 3 first posted: Biocad, BCD-248 + daratumumab + Daratumumab + pomalidomide + dexamethasone (NCT07742215)
- 2026-07-27Phase 3 first posted: AbbVie, Etentamig + Pomalidomide (NCT07728188)
- 2026-07-13Also stopped (suspended): Hackensack Meridian Health, Carfilzomib + Iberdomide (NCT05199311)
- 2026-07-09Also stopped (terminated): Celgene, BB2121 + CC-220 (NCT04855136)
- 2026-06-25Results posted on the registry: GlaxoSmithKline, Belantamab mafodotin + Nirogacestat (NCT07150104)
- 2026-06-03Phase 3 first posted: Dana-Farber Cancer Institute, Isatuximab + Iberdomide (NCT07624513)
- 2026-06-03Phase 3 first posted: Innovent Biologics (Suzhou) Co. Ltd., Pomalidomide Capsules + Bortezomib for Injection (NCT07623798)
- 2026-05-22Results posted on the registry: Celgene, Pomalidomide + Dexamethasone (NCT01946477)
- 2026-05-20Results posted on the registry: UNC Lineberger Comprehensive Cancer Center, Isatuximab + Pomalidomide (NCT05911321)
- 2026-05-20Results posted on the registry: Weill Medical College of Cornell University, Daratumumab SC + Clarithromycin (NCT04302324)
- 2026-05-12Phase 3 first posted: Shandong New Time Pharmaceutical Co., LTD, F182112 single-agent + Pomalidomide + Bortezomib + Dexamethasone (PVd) or Selinexor + Bortezomib + Dexamethasone (SVd) (NCT07579234)
- 2026-05-06Phase 3 first posted: Chia Tai Tianqing Pharmaceutical Group Co., Ltd., TQB2934 injection + Pomalidomide Capsule (NCT07569757)
- 2026-05-06Results posted on the registry: GlaxoSmithKline, Belantamab mafodotin + GSK3174998 (NCT04126200)
- 2026-04-29Phase 3 first posted: Hoffmann-La Roche, Cevostamab + Pomalidomide (NCT07555938)
- 2026-03-20Results posted on the registry: Celgene, CC-220 + Dexamethasone (NCT02773030)
- 2026-03-06Results posted on the registry: University of Colorado, Denver, Selinexor + Pomalidomide (NCT04925193)
- 2026-03-05Phase 3 first posted: Genrix (Shanghai) Biopharmaceutical Co., Ltd., GR1803 injection + Daratumumab (NCT07452198)
- 2026-02-06Phase 3 first posted: AstraZeneca, AZD0120 + Daratumumab (NCT07391657)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision